Nicholas Lemoine Selected Research

Margins of Excision

4/2005

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas Lemoine Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 04/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 04/2005
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Malignant Mesothelioma 01/2017
1	Fatigue 01/2017
1	Mesothelioma 01/2017
1	Neutropenia 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Carcinoma (Carcinomatosis) 01/2006
1	Margins of Excision 04/2005
1	Neoplasm Metastasis (Metastasis) 04/2005

Drug/Important Bio-Agent (IBA)

1	interleukin-21 (interleukin 21)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2020
1	Thymidine KinaseIBA 01/2020
1	arginine deiminaseIBA 01/2017
1	ADI PEG20IBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2017
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	LuciferasesIBA 01/2006
1	Icodextrin (Extraneal)FDA Link 01/2006
1	Viral ProteinsIBA 01/2006
1	dl1520 (ONYX-015)IBA 01/2006
1	Indicators and Reagents (Reagents)IBA 04/2005
1	NF-kappa B (NF-kB)IBA 04/2005
1	S100 Calcium Binding Protein A6IBA 04/2005

Therapy/Procedure

1	Therapeutics 01/2021
1	Neoadjuvant Therapy 01/2020